Clinicopathological and molecular genetic characteristics of Epstein–Barr virus‐positive small cell neuroendocrine carcinoma of the nasopharynx
Histopathology · 2026
DOI: 10.1111/his.70118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Lu Jian-Ping und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms, Carcinoma, Small Cell. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Medical Innovation Program of Fujian Provincial Healthcare Commission, Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology, Fujian Province.
Abstract (Originalsprache)
Background
Epstein–Barr virus (EBV)‐positive small cell neuroendocrine carcinoma of the nasopharynx (SCNEC‐nasopharynx) is exceptionally rare and aggressive, with poorly characterized molecular features.
Methods
Clinicopathological, immunohistochemical (synaptophysin, INSM1, chromogranin A, CK‐pan, EGFR, NUT, INI1), and molecular profiles of 15 EBV‐positive SCNEC‐nasopharynx cases (2012–2025) were analysed. EBV status was confirmed by EBER‐ISH. Exploratory next‐generation sequencing compared nine SCNEC with five EBV‐positive nasopharyngeal non‐keratinizing carcinomas (NKUC).
Results
Patients (median age 51; male:female = 2:1) presented with advanced‐stage disease and cervical lymphadenopathy. Histology showed solid nests of small cells with high‐grade features. All tumours were diffusely positive for synaptophysin and EBER, showed perinuclear dot‐like CK‐pan staining, and were negative for squamous markers and EGFR. NUT was negative and INI1 retained. Comparative genomics revealed greater mutational burden and unique alterations enriched in cell cycle/DNA damage pathways in SCNEC versus NKUC. After multimodal therapy, median overall survival was 33 months.
Conclusion
This largest integrated study defines the distinct clinicopathological and molecular profile of EBV‐positive SCNEC‐nasopharynx. The identified diagnostic immunophenotype and potential oncogenic pathways provide a foundation for precise diagnosis and future targeted therapy development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
- Department of Pathology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
- Department of Molecular Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
ORCID-Profile: Lu Jian-Ping, Xie Yun-Li, Wang Xiao-Jiang, Zhu Huan-Huan, Lu Shu-Yi, Zhang Wen-Wen, Ke Long-Feng, Chen Gang, Chen Yan-Ping
Förderung
- Medical Innovation Program of Fujian Provincial Healthcare Commission
- Natural Science Foundation of Fujian Province
- Joint Funds for the Innovation of Science and Technology, Fujian Province
Zitieren
APA
Jian-Ping, L., Yun-Li, X., Xiao-Jiang, W., Huan-Huan, Z., Shu-Yi, L., Wen-Wen, Z., Long-Feng, K., Gang, C., & Yan-Ping, C. (2026). Clinicopathological and molecular genetic characteristics of Epstein–Barr virus‐positive small cell neuroendocrine carcinoma of the nasopharynx. Histopathology. https://doi.org/10.1111/his.70118
Vancouver
Jian-Ping L, Yun-Li X, Xiao-Jiang W, Huan-Huan Z, Shu-Yi L, Wen-Wen Z, et al. Clinicopathological and molecular genetic characteristics of Epstein–Barr virus‐positive small cell neuroendocrine carcinoma of the nasopharynx. Histopathology. 2026. doi:10.1111/his.70118
BibTeX
@article{JianPing2026,
author = {Jian-Ping, Lu and Yun-Li, Xie and Xiao-Jiang, Wang and Huan-Huan, Zhu and Shu-Yi, Lu and Wen-Wen, Zhang and Long-Feng, Ke and Gang, Chen and Yan-Ping, Chen},
title = {Clinicopathological and molecular genetic characteristics of Epstein–Barr virus‐positive small cell neuroendocrine carcinoma of the nasopharynx},
journal = {Histopathology},
year = {2026},
doi = {10.1111/his.70118}
}
EUVIMED